Amount Raised
$12 Million
Round Type
Venture
San DiegoBiotechnologyHealthcareHealth CareBiotechnology ResearchDescription
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it has entered into a royalty-backed financing agreement that provides Daré with $5 million at closing and up to an additional $7 million through three tranches over time at Daré’s option. The financing structure entitles the investor to a percentage of the royalties and milestones to be received by Daré under its global license agreement for XACIATOTM with Organon only until the investor achieves a targeted return on investment.
Quick answer
Daré Bioscience, Inc. raised $12 Million in a funding round, dated December 26, 2023. Daré Bioscience, Inc. is based in San Diego, California, United States.
- How much did Daré Bioscience, Inc. raise?
- Daré Bioscience, Inc. raised $12 Million in a funding round on December 26, 2023.
- What does Daré Bioscience, Inc. do?
- Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health.
- Where is Daré Bioscience, Inc. based and how big is it?
- Daré Bioscience, Inc. is based in San Diego, California, United States. Fundz records about 28 employees.
- Who are the decision-makers at Daré Bioscience, Inc?
- Fundz holds 1 contact at Daré Bioscience, Inc., including the President and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology Research around the same time
Companies in the same sectors as Daré Bioscience, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Vaccinex raised $3.7M (Seed) on February 8, 2024.
- Greenbrook TMS raised $1.5M (Seed) on February 6, 2024.
- Aclarion raised $3M (Seed) on February 6, 2024.
- Shape Memory Medical raised $30M on February 6, 2024.
- Procyrion raised $58M (Series E) on February 5, 2024.
- Vektor Medical raised $16M (Series A) on February 5, 2024.
Who to call at Daré Bioscience, Inc., and when
A new round usually means Daré Bioscience, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Daré Bioscience, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Daré Bioscience, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Daré Bioscience, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Daré Bioscience, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Daré Bioscience, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.